SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
黄焖鸡米饭
Lv1
28 积分
2023-10-23 加入
最近求助
最近应助
互助留言
FGFR redundancy limits the efficacy of FGFR4-selective inhibitors in hepatocellular carcinoma
9小时前
已完结
Discovery of aHighly Potent and Selective HDAC8 Degrader: Advancing the Functional Understanding and Therapeutic Potential of HDAC8
13天前
已完结
H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma
21天前
已完结
Design, synthesis, and biological evaluation of selective covalent inhibitors of FGFR4
21天前
已完结
Drug development using pancreatic and lung organoid models
24天前
已关闭
Drug development using pancreatic and lung organoid models
25天前
已关闭
Chapter 14 - Drug development using pancreatic and lung organoid models
25天前
已关闭
Design, synthesis, and biological evaluation of naphthalene imidazo[1,2-b]pyridazine hybrid derivatives as VEGFR selective inhibitors
25天前
已完结
A Prostate-Specific Membrane Antigen-Targeting Small Molecule–Drug Conjugate Strategy to Overcome the Hematological Toxicity of Olaparib
29天前
已完结
Discovery of ZLC491 as a Potent, Selective, and Orally Bioavailable CDK12/13 PROTAC Degrader
1个月前
已完结
没有进行任何应助
没有进行任何互助留言
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论